Sunto-gun, Japan

Jun-ichi Saito


Average Co-Inventor Count = 9.7

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Sunto-gun, JP (2009 - 2010)
  • Tokyo, JP (2019)

Company Filing History:


Years Active: 2009-2019

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Jun-ichi Saito: Innovator in Oligonucleotide Technology

Introduction

Jun-ichi Saito is a prominent inventor based in Sunto-gun, Japan. He has made significant contributions to the field of oligonucleotide technology, holding a total of 4 patents. His work focuses on improving the affinity and knockdown activity of oligonucleotides, which are crucial in various biomedical applications.

Latest Patents

Saito's latest patents include innovative oligonucleotides designed to enhance their effectiveness. One notable patent discloses an oligonucleotide with improved affinity for AGO2, featuring specific nucleotide residues that facilitate binding to adjacent residues. Another patent presents an oligonucleotide with a non-natural nucleotide at the 5' terminal, which also binds through the oxygen atom at position 3. These advancements aim to improve the knockdown activity against mRNA encoding proteins involved in diseases.

Career Highlights

Throughout his career, Jun-ichi Saito has worked with notable companies such as Kyowa Hakko Kirin Co., Limited and Kyowa Hakko Kogyo Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas in oligonucleotide technology.

Collaborations

Saito has collaborated with esteemed colleagues, including Shinji Nara and Hiroshi Nakagawa. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Jun-ichi Saito's contributions to oligonucleotide technology demonstrate his commitment to innovation in the field. His patents reflect a deep understanding of molecular interactions and their potential applications in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…